Vivo Bio Tech Ltd — Important, 20-08-2025: Company Update
20-08-2025 | 11:44 am
20-08-2025 | 11:44 am
Vivo Bio Tech Limited has secured a significant pre-clinical testing contract valued at ₹10.75 Crores. This contract, in collaboration with a leading Indian Pharma and Agro-Chemical major, involves conducting comprehensive pre-clinical safety and regulatory studies for a novel molecule. The scope spans toxicity, mutagenicity, ecotoxicology, and analytical services, to be completed within two years. This landmark deal strengthens Vivo Bio Tech's position as a key partner in the life sciences sector and highlights its advanced capabilities in delivering integrated pre-clinical solutions, paving the way for future growth and collaborations.
No comments yet. Be the first to comment!
